AZTA
Price
$37.18
Change
-$0.69 (-1.82%)
Updated
Oct 14 closing price
Capitalization
1.5B
33 days until earnings call
Intraday BUY SELL Signals
INSP
Price
$68.07
Change
-$0.79 (-1.15%)
Updated
Oct 14 closing price
Capitalization
2.02B
18 days until earnings call
Intraday BUY SELL Signals
Interact to see
Advertisement

AZTA vs INSP

AZTA vs INSP Comparison Chart in %
View a ticker or compare two or three
VS
AZTA vs. INSP commentary
Oct 15, 2026

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is AZTA is a Hold and INSP is a Hold.

Interact to see
Advertisement
SUMMARIES
A.I.Advisor
a Summary for AZTA with price predictions
Oct 14, 2026

Aroon Indicator for AZTA shows an upward move is likely

AZTA's Aroon Indicator triggered a bullish signal on October 14, 2026. Tickeron's A.I.dvisor detected that the AroonUp green line is above 70 while the AroonDown red line is below 30. When the up indicator moves above 70 and the down indicator remains below 30, it is a sign that the stock could be setting up for a bullish move. Traders may want to buy the stock or look to buy calls options. A.I.dvisor looked at 177 similar instances where the Aroon Indicator showed a similar pattern. In 144 of the 177 cases, the stock moved higher in the days that followed. This puts the odds of a move higher at 81%.

Price Prediction Chart

Technical Analysis (Indicators)

Bullish Trend Analysis

The Stochastic Oscillator is in the oversold zone. Keep an eye out for a move up in the foreseeable future.

The Momentum Indicator moved above the 0 level on September 15, 2026. You may want to consider a long position or call options on AZTA as a result. In 64 of 84 past instances where the momentum indicator moved above 0, the stock continued to climb. The odds of a continued upward trend are 76%.

The Moving Average Convergence Divergence (MACD) for AZTA just turned positive on September 17, 2026. Looking at past instances where AZTA's MACD turned positive, the stock continued to rise in 38 of 49 cases over the following month. The odds of a continued upward trend are 78%.

Following a +0.40% 3-day Advance, the price is estimated to grow further. Considering data from situations where AZTA advanced for three days, in 217 of 301 cases, the price rose further within the following month. The odds of a continued upward trend are 72%.

Bearish Trend Analysis

The 10-day RSI Indicator for AZTA moved out of overbought territory on October 06, 2026. This could be a bearish sign for the stock. Traders may want to consider selling the stock or buying put options. Tickeron's A.I.dvisor looked at 31 similar instances where the indicator moved out of overbought territory. In 23 of the 31 cases, the stock moved lower in the following days. This puts the odds of a move lower at 74%.

Following a 3-day decline, the stock is projected to fall further. Considering past instances where AZTA declined for three days, the price rose further in 50 of 62 cases within the following month. The odds of a continued downward trend are 81%.

AZTA broke above its upper Bollinger Band on October 02, 2026. This could be a sign that the stock is set to drop as the stock moves back below the upper band and toward the middle band. You may want to consider selling the stock or exploring put options.

Fundamental Analysis (Ratings)

The Tickeron Seasonality Score of 4 (best 1 - 100 worst) indicates that the company is seriously undervalued in the industry. The Tickeron Seasonality score describes the variance of predictable price changes around the same period every calendar year. These changes can be tied to a specific month, quarter, holiday or vacation period, as well as a meteorological or growing season.

The Tickeron Price Growth Rating for this company is 36 (best 1 - 100 worst), indicating steady price growth. AZTA’s price grows at a higher rate over the last 12 months as compared to S&P 500 index constituents.

The Tickeron Valuation Rating of 48 (best 1 - 100 worst) indicates that the company is fair valued in the industry. This rating compares market capitalization estimated by our proprietary formula with the current market capitalization. This rating is based on the following metrics, as compared to industry averages: P/B Ratio (0.994) is normal, around the industry mean (5.011). P/E Ratio (42.431) is within average values for comparable stocks, (163.451). Projected Growth (PEG Ratio) (0.310) is also within normal values, averaging (4.456). Dividend Yield (0.002) settles around the average of (0.005) among similar stocks. P/S Ratio (2.485) is also within normal values, averaging (56.074).

The Tickeron PE Growth Rating for this company is 84 (best 1 - 100 worst), pointing to worse than average earnings growth. The PE Growth rating is based on a comparative analysis of stock PE ratio increase over the last 12 months compared against S&P 500 index constituents.

The Tickeron SMR rating for this company is 93 (best 1 - 100 worst), indicating weak sales and an unprofitable business model. SMR (Sales, Margin, Return on Equity) rating is based on comparative analysis of weighted Sales, Income Margin and Return on Equity values compared against S&P 500 index constituents. The weighted SMR value is a proprietary formula developed by Tickeron and represents an overall profitability measure for a stock.

The Tickeron Profit vs. Risk Rating rating for this company is 100 (best 1 - 100 worst), indicating that the returns do not compensate for the risks. AZTA’s unstable profits reported over time resulted in significant Drawdowns within these last five years. A stable profit reduces stock drawdown and volatility. The average Profit vs. Risk Rating rating for the industry is 96, placing this stock worse than average.

A.I.Advisor
a Summary for INSP with price predictions
Oct 14, 2026

INSP in -4.78% downward trend, sliding for three consecutive days on October 14, 2026

Moving lower for three straight days is viewed as a bearish sign. Keep an eye on this stock for future declines. Considering data from situations where INSP declined for three days, in 249 of 319 cases, the price declined further within the following month. The odds of a continued downward trend are 78%.

Price Prediction Chart

Technical Analysis (Indicators)

Bearish Trend Analysis

The 10-day RSI Indicator for INSP moved out of overbought territory on September 22, 2026. This could be a bearish sign for the stock. Traders may want to consider selling the stock or buying put options. Tickeron's A.I.dvisor looked at 30 similar instances where the indicator moved out of overbought territory. In 20 of the 30 cases, the stock moved lower in the following days. This puts the odds of a move lower at 67%.

The Momentum Indicator moved below the 0 level on October 13, 2026. You may want to consider selling the stock, shorting the stock, or exploring put options on INSP as a result. In 64 of 84 cases where the Momentum Indicator fell below 0, the stock fell further within the subsequent month. The odds of a continued downward trend are 76%.

The Moving Average Convergence Divergence Histogram (MACD) for INSP turned negative on September 23, 2026. This could be a sign that the stock is set to turn lower in the coming weeks. Traders may want to sell the stock or buy put options. Tickeron's A.I.dvisor looked at 44 similar instances when the indicator turned negative. In 33 of the 44 cases the stock turned lower in the days that followed. This puts the odds of success at 75%.

INSP broke above its upper Bollinger Band on September 09, 2026. This could be a sign that the stock is set to drop as the stock moves back below the upper band and toward the middle band. You may want to consider selling the stock or exploring put options.

Bullish Trend Analysis

The Stochastic Oscillator suggests the stock price trend may be in a reversal from a downward trend to an upward trend. 45 of 59 cases where INSP's Stochastic Oscillator exited the oversold zone resulted in an increase in price. Tickeron's analysis proposes that the odds of a continued upward trend are 76%.

The 50-day moving average for INSP moved above the 200-day moving average on September 30, 2026. This could be a long-term bullish signal for the stock as the stock shifts to an upward trend.

Following a +7.20% 3-day Advance, the price is estimated to grow further. Considering data from situations where INSP advanced for three days, in 231 of 282 cases, the price rose further within the following month. The odds of a continued upward trend are 82%.

The Aroon Indicator entered an Uptrend today. In 146 of 199 cases where INSP Aroon's Indicator entered an Uptrend, the price rose further within the following month. The odds of a continued Uptrend are 73%.

Fundamental Analysis (Ratings)

The Tickeron Price Growth Rating for this company is 42 (best 1 - 100 worst), indicating steady price growth. INSP’s price grows at a higher rate over the last 12 months as compared to S&P 500 index constituents.

The Tickeron SMR rating for this company is 50 (best 1 - 100 worst), indicating strong sales and a profitable business model. SMR (Sales, Margin, Return on Equity) rating is based on comparative analysis of weighted Sales, Income Margin and Return on Equity values compared against S&P 500 index constituents. The weighted SMR value is a proprietary formula developed by Tickeron and represents an overall profitability measure for a stock.

The Tickeron Valuation Rating of 57 (best 1 - 100 worst) indicates that the company is fair valued in the industry. This rating compares market capitalization estimated by our proprietary formula with the current market capitalization. This rating is based on the following metrics, as compared to industry averages: P/B Ratio (2.451) is normal, around the industry mean (10.930). P/E Ratio (15.453) is within average values for comparable stocks, (100.178). Projected Growth (PEG Ratio) (0.000) is also within normal values, averaging (11.052). Dividend Yield (0.000) settles around the average of (0.002) among similar stocks. P/S Ratio (2.375) is also within normal values, averaging (40.124).

The Tickeron Seasonality Score of 95 (best 1 - 100 worst) indicates that the company is significantly overvalued in the industry. The Tickeron Seasonality score describes the variance of predictable price changes around the same period every calendar year. These changes can be tied to a specific month, quarter, holiday or vacation period, as well as a meteorological or growing season.

The Tickeron PE Growth Rating for this company is 97 (best 1 - 100 worst), pointing to worse than average earnings growth. The PE Growth rating is based on a comparative analysis of stock PE ratio increase over the last 12 months compared against S&P 500 index constituents.

The Tickeron Profit vs. Risk Rating rating for this company is 100 (best 1 - 100 worst), indicating that the returns do not compensate for the risks. INSP’s unstable profits reported over time resulted in significant Drawdowns within these last five years. A stable profit reduces stock drawdown and volatility. The average Profit vs. Risk Rating rating for the industry is 96, placing this stock worse than average.

FUNDAMENTALS RATINGS
AZTA vs INSP: Fundamental Ratings
AZTA
INSP
OUTLOOK RATING
1..100
3969
VALUATION
overvalued / fair valued / undervalued
1..100
48
Fair valued
57
Fair valued
PROFIT vs RISK RATING
1..100
100100
SMR RATING
1..100
9350
PRICE GROWTH RATING
1..100
3642
P/E GROWTH RATING
1..100
8497
SEASONALITY SCORE
1..100
490

Tickeron ratings are formulated such that a rating of 1 designates the most successful stocks in a given industry, while a rating of 100 points to the least successful stocks for that industry.

AZTA's Valuation (48) in the Electronic Production Equipment industry is in the same range as INSP (57) in the Medical Specialties industry. This means that AZTA’s stock grew similarly to INSP’s over the last 12 months.

AZTA's Profit vs Risk Rating (100) in the Electronic Production Equipment industry is in the same range as INSP (100) in the Medical Specialties industry. This means that AZTA’s stock grew similarly to INSP’s over the last 12 months.

INSP's SMR Rating (50) in the Medical Specialties industry is somewhat better than the same rating for AZTA (93) in the Electronic Production Equipment industry. This means that INSP’s stock grew somewhat faster than AZTA’s over the last 12 months.

AZTA's Price Growth Rating (36) in the Electronic Production Equipment industry is in the same range as INSP (42) in the Medical Specialties industry. This means that AZTA’s stock grew similarly to INSP’s over the last 12 months.

AZTA's P/E Growth Rating (84) in the Electronic Production Equipment industry is in the same range as INSP (97) in the Medical Specialties industry. This means that AZTA’s stock grew similarly to INSP’s over the last 12 months.

TECHNICAL ANALYSIS
Technical Analysis
AZTAINSP
RSI
ODDS (%)
Bearish Trend 1 day ago
74%
Bearish Trend 1 day ago
67%
Stochastic
ODDS (%)
Bullish Trend 1 day ago
69%
Bullish Trend 1 day ago
76%
Momentum
ODDS (%)
Bullish Trend 1 day ago
76%
Bearish Trend 1 day ago
76%
MACD
ODDS (%)
Bullish Trend 1 day ago
78%
Bearish Trend 1 day ago
75%
TrendWeek
ODDS (%)
Bullish Trend 1 day ago
72%
Bullish Trend 1 day ago
77%
TrendMonth
ODDS (%)
Bullish Trend 1 day ago
75%
Bearish Trend 1 day ago
85%
Advances
ODDS (%)
Bullish Trend 2 days ago
72%
Bullish Trend 3 days ago
82%
Declines
ODDS (%)
Bearish Trend 8 days ago
81%
Bearish Trend 1 day ago
78%
BollingerBands
ODDS (%)
Bearish Trend 1 day ago
78%
Bearish Trend 6 days ago
71%
Aroon
ODDS (%)
Bullish Trend 1 day ago
81%
Bullish Trend 1 day ago
73%
COMPARISON
Comparison
Oct 15, 2026
Stock price -- (AZTA: $37.18 vs. INSP: $68.07)
Brand notoriety: AZTA and INSP are both not notable
AZTA represents the Pharmaceuticals: Other, while INSP is part of the Medical/Nursing Services industry
Current volume relative to the 65-day Moving Average: AZTA: 89% vs. INSP: 111%
Market capitalization -- AZTA: $1.5B vs. INSP: $2.02B
AZTA [@Pharmaceuticals: Other] is valued at $1.5B. INSP’s [@Medical/Nursing Services] market capitalization is $2.02B. The market cap for tickers in the [@Pharmaceuticals: Other] industry ranges from $126 to $146.54B. The market cap for tickers in the [@Medical/Nursing Services] industry ranges from $837 to $174.73B. The average market capitalization across the [@Pharmaceuticals: Other] industry is $8.89B. The average market capitalization across the [@Medical/Nursing Services] industry is $5.59B.

Long-Term Analysis

It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is overvalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).

AZTA’s FA Score shows that 0 FA rating(s) are green while INSP’s FA Score has 0 green FA rating(s).

  • AZTA’s FA Score: 0 green, 5 red.
  • INSP’s FA Score: 0 green, 5 red.
According to our system of comparison, INSP is a better buy in the long-term than AZTA.

Short-Term Analysis

It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.

If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.

AZTA’s TA Score shows that 5 TA indicator(s) are bullish while INSP’s TA Score has 4 bullish TA indicator(s).

  • AZTA’s TA Score: 5 bullish, 3 bearish.
  • INSP’s TA Score: 4 bullish, 5 bearish.
According to our system of comparison, AZTA is a better buy in the short-term than INSP.

Price Growth

AZTA (@Pharmaceuticals: Other) experienced а +3.59% price change this week, while INSP (@Medical/Nursing Services) price change was +0.92% for the same time period.

The average weekly price growth across all stocks in the @Pharmaceuticals: Other industry was -0.96%. For the same industry, the average monthly price growth was -4.87%, and the average quarterly price growth was +3.79%.

The average weekly price growth across all stocks in the @Medical/Nursing Services industry was -4.79%. For the same industry, the average monthly price growth was -7.51%, and the average quarterly price growth was -14.87%.

Reported Earning Dates

AZTA is expected to report earnings on Nov 17, 2026.

INSP is expected to report earnings on Nov 02, 2026.

Industries' Descriptions

@Pharmaceuticals: Other (-0.96% weekly)

Pharmaceuticals (Other) comprise companies that are involved in the discovery, development or manufacturing of therapeutic and preventative medicines. They often collaborate with or acquire other pharmaceutical/healthcare firms. Examples of companies in this segment include Bausch Health Companies Inc., Icon Plc and Perrigo Company Plc.

@Medical/Nursing Services (-4.79% weekly)

The medical/nursing services includes companies that provide medical-related services such as ambulance services, dialysis centers, respiratory therapy, blood testing and rehabilitation services. DaVita Inc., Chemed Corporation and Guardant Health, Inc. are examples of companies in this industry.

View a ticker or compare two or three
AZTA
Daily Signal:
Gain/Loss:
INSP
Daily Signal:
Gain/Loss:
Interact to see
Advertisement
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
STOCK / NAMEPrice $Chg $Chg %
PCTY159.100.99
+0.63%
Paylocity Holding Corp
POCT48.16-0.32
-0.66%
Innovator U.S. Equity Power Buffer ETF - October (POCT)
FOSL6.90-0.25
-3.50%
Fossil Group
KMTS25.47-1.50
-5.56%
Kestra Medical Technologies, Ltd.
AVD1.13-0.20
-15.04%
American Vanguard Corp

AZTA and

Correlation & Price change

A.I.dvisor indicates that over the last year, AZTA has been loosely correlated with IQV. These tickers have moved in lockstep 60% of the time. This A.I.-generated data suggests there is some statistical probability that if AZTA jumps, then IQV could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To AZTA
1D Price
Change %
AZTA100%
-1.82%
IQV - AZTA
60%
Loosely correlated
+0.51%
RVTY - AZTA
59%
Loosely correlated
-1.91%
A - AZTA
59%
Loosely correlated
+1.40%
MTD - AZTA
59%
Loosely correlated
+0.70%
BRKR - AZTA
58%
Loosely correlated
-1.05%
More

INSP and

Correlation & Price change

A.I.dvisor indicates that over the last year, INSP has been loosely correlated with VIVO. These tickers have moved in lockstep 41% of the time. This A.I.-generated data suggests there is some statistical probability that if INSP jumps, then VIVO could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To INSP
1D Price
Change %
INSP100%
-1.15%
VIVO - INSP
41%
Loosely correlated
-15.77%
LIVN - INSP
38%
Loosely correlated
-0.38%
AZTA - INSP
37%
Loosely correlated
-1.82%
CSTL - INSP
35%
Loosely correlated
+0.70%
SIBN - INSP
34%
Loosely correlated
-1.07%
More